INTRODUCTION AND PROGRAM DESCRIPTION
eMedicine is delighted to offer this free CME activity based on presentations given at the 2006 World Parkinson Congress in Washington, DC, on February 22, 2006. The Movement Disorder Society (MDS) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. MDS designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™.

Persons who attended these presentations are NOT eligible to receive AMA PRA Category 1 Credit for completing this enduring material. Please note that the course is accredited only for physicians (MD, DO, or equivalent). All other participants receive a certificate of completion.

Parkinson disease is a progressive movement disorder that affects nearly 1 million US adults. Approximately 40,000 people are diagnosed with Parkinson disease each year in the United States. Although a cure does not presently exist, surgical and pharmacotherapeutic advances have led to improved treatment options and delivery methods for patients with Parkinson disease.

This CME activity examines the role of the transdermal patch in antiparkinsonian drug delivery for the treatment of Parkinson disease. Specific disease management concepts, novel delivery methods, and the emerging role of the rotigotine transdermal system in the treatment of patients with advanced-stage Parkinson disease are discussed.

This activity is composed of the following audio/slide/video presentations: Novel Methods for Drug Delivery in Parkinson Disease (Kapil Sethi, MD, FRCP) Rotigotine – Patch Delivery of a Dopamine Agonist (Cheryl Waters, MD, FRCP) Question-and-Answer/Discussion Session